Bone growth stimulators include the medical devices (external and internal bone growth stimulators) and biologics (PRP and BMP); that are used during or post or after orthopedic treatments related to bone regeneration (including spine fusion surgery, bone fractures, and bone grafts, among others) in order to enhance the bone healing process.

Bone Growth Stimulators Devices offer a cost-effective and safer alternative mode to treat orthopedic diseases as compared to traditional surgical therapies for nonunion bone fractures. These devices have been reported to shorten the patient’s hospital stay as well as lessen the risks of complications and infections.

According to Latest Market research report Published by MarketsandMarkets the “Bone Growth Stimulators Market Size, Share, Demand and Growth Analysis, forecast” the global Market is estimated to reach USD 1.41 billion, at a CAGR of 5.4%.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82341383

key players operating in the Global Bone Growth Stimulators Market;

Orthofix International N.V. (U.S.), DJO Finance LLC (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Bioventus LLC (U.S.), Medtronic plc (Ireland), Stryker Corporation (U.S.), DePuy Synthes (U.S.), Arthrex, Inc. (U.S.), and Harvest Technologies Corporation (U.S.)

Orthofix International N.V. held the leading position in the market in 2016. The company offers its non-invasive bone growth stimulators through its BioStim business segment. It has a strong presence in North America, Europe, the Middle East, Africa, Asia-Pacific, and other countries. Orthofix has a strong geographic presence in 65 countries including in the U.S., the U.K., Italy, Germany, Switzerland, Austria, France, Brazil, Australia, and Puerto Rico.

Major Drivers Impacting the Bone Growth Stimulators Market;

· Growing Patient Preference for Noninvasive and Minimally Invasive Surgical Treatments

· Increasing Target Patient Population

· Procedural Benefits Offered by Bone Stimulation Devices in Bone Fracture Treatment

Speak to Our Subject Expert:

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=82341383

Global Bone Growth Stimulators Market Segmentation:

On the basis of product, the global bone growth stimulators market is segmented into bone growth stimulation devices, bone morphogenetic protein (BMPs), and platelet-rich plasma (PRP). The bone growth stimulation devices segment accounted for the largest share of the market

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=82341383

On the basis of end user, the global bone growth stimulators market is segmented into hospitals & clinics, home care, and academic & research institutes and CROs. The hospitals & clinics segment is expected to grow at the highest CAGR during the forecast period. The advantage of bone growth stimulation products over their counterparts is the key factor driving their adoption in this end-user segment.